CMDBioscienceSM
Latest round
- Series A
Last raised
- Dec 2012
Total raised
- $1M
Investors
- 3
About CMDBioscienceSM
CMDBioscienceSM Inc.CMDBioscienceSM Inc. is engaged in the synthesis of DNA and RNA oligonucleotides. The company is headquartered in New Haven, US. On December 24, 2012, CMDBioscienceSM Inc.CMD Biosciences specializes in the synthesis of DNA and RNA oligonucleotides, offering a comprehensive range of over 100 modifications tailored to meet diverse research needs. Their core product line includes guaranteed oligos that are deprotected, desalted, and PAGE controlled, ensuring high purity and reliability for laboratory applications. Customers can order oligos with various labels, including fluorescent and non-fluorescent options, and other chemical modifications suited for hybridization probes, making their products essential for molecular biology research, diagnostics, and therapeutic development.CMD Biosciences operates on a transactional model where customers place orders for oligos through their web-based platform. Typical transactions involve the purchase of custom oligonucleotides in various quantities, ranging from Mass Oligos to Bulk Oligos, allowing clients to select specific modifications and labeling options. Pricing structures are designed to accommodate both small-scale and large-scale orders, with expedited shipping options available for time-sensitive research needs. The company’s flagship offerings, such as their Mass Oligos™, are particularly favored for their quick delivery turnaround, reinforcing their position in the competitive life sciences market.0 mn, the company plans to leverage these funds to enhance its product offerings and expand its market reach. Upcoming projects include the launch of new oligonucleotide modifications aimed at expanding their product line. The company aims to enter new geographic markets in Europe and Asia by 2024, targeting academic and pharmaceutical sectors that require advanced molecular biology tools.
Who invested in CMDBioscienceSM
3 investors across 1 round
See all investors in CMDBioscienceSM
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 24, 2012
Amount
$1M
Investors
Questions about CMDBioscienceSM
Who invested in CMDBioscienceSM?
CMDBioscienceSM has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CMDBioscienceSM raised?
CMDBioscienceSM has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CMDBioscienceSM last raise money?
CMDBioscienceSM's most recent round on record is a Series A, in Dec 2012.
What does CMDBioscienceSM do?
CMDBioscienceSM is a healthcare it company.
Where is CMDBioscienceSM headquartered?
CMDBioscienceSM is headquartered in New Haven, US.
Which VCs invest in companies like CMDBioscienceSM?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at CMDBioscienceSM's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series A
Raising like CMDBioscienceSM? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.